Moderna (MRNA) stock has fallen since the last week’s announcement of a possible vaccine for COVID-19. Its CEO has indicated that the prices for the coronavirus vaccine will be affordable.Moderna Inc (NASDAQ: MRNA) stock remained low. It lost 1.5% yesterday and today in the premarket it is nearly 4% down. This comes as the CEO of the biotech startup has indicated that the company’s COVID-19 vaccine will be affordable. Sources report that Stephane Bancel said that the price will be within the...
Read More »